<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">STAR Protoc</span><span class="iso-abbrev" title="iso-abbrev">STAR Protoc</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">STAR Protocols</span></div><span class="issn-epub" tagx="issn" title="issn-epub">2666-1667</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Elsevier</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7856476">7856476</a></span><span class="pii" title="pii">S2666-1667(21)00019-8</span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1016/j.xpro.2021.100312">10.1016/j.xpro.2021.100312</a></span><span class="publisher-id" title="publisher-id">100312</span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Protocol</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Protocol for hit-to-lead optimization of compounds by auto <i>in silico</i> ligand directing evolution (AILDE) approach</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mei</span><span class="given-names" tagx="given-names" title="given-names">Longcan</span></span><a href="#aff1">1</a><a href="#aff2">2</a><a href="#fn1">5</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">Fengxu</span></span><a href="#aff1">1</a><a href="#aff2">2</a><a href="#fn1">5</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hao</span><span class="given-names" tagx="given-names" title="given-names">Gefei</span></span><span class="email" tagx="email" title="email">gefei_hao@foxmail.com</span><a href="#aff1">1</a><a href="#aff2">2</a><a href="#aff3">3</a><a href="#fn2">6</a><a href="#fn3">7</a><a href="#cor1">âˆ—</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">Guangfu</span></span><a href="#aff1">1</a><a href="#aff2">2</a><a href="#aff4">4</a></span><span class="citation_author_institution" id="aff1">[1], </span><span class="citation_author_institution" id="aff2">[2], </span><span class="citation_author_institution" id="aff3">[3], </span><span class="citation_author_institution" id="aff4">[4], </span></div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><span class="label" tagx="label" title="label">âˆ—</span>Corresponding author <span class="email" tagx="email" title="email">gefei_hao@foxmail.com</span></div> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">5</span><p id="ntpara0010">These authors contributed equally</p> </div> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">6</span><p id="ntpara0015">Technical contact</p> </div> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">7</span><p id="ntpara0020">Lead contact</p> </div> </div><span class="pub-date-pmc-release" title="pub-date-pmc-release">pmc-release: <span>2021-2-2</span></span><span class="pub-date-collection" title="pub-date-collection">collection: <span>2021-3-3</span></span><span class="pub-date-epub" title="pub-date-epub">epub: <span>2021-2-2</span></span><span class="volume" tagx="volume" title="volume">2</span><span class="issue" tagx="issue" title="issue">1</span><span class="elocation-id" tagx="elocation-id" title="elocation-id">100312</span><div class="permissions"><span class="copyright" title="copyright">(C) , <span class="copyright-year" tagx="copyright-year" title="copyright-year">2021</span></span><span class="license" title="license"><span class="license-p" title="license-p">This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</span></span></div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="title" tagx="title" title="title">
Summary</div> <p>Hit-to-lead (H2L) optimization is crucial for drug design, which has become an increasing concern in medicinal chemistry. A virtual screening strategy of auto <i>in silico</i> ligand directing evolution (AILDE) has been developed to yield promising lead compounds rapidly and efficiently. The protocol includes instructions for fragment compound library construction, conformational sampling by molecular dynamics simulation, ligand modification by fragment growing, as well as the binding free energy prediction.</p> <p>For complete details on the use and execution of this protocol, please refer to <a href="#bib11">Wu etÂ al. (2020)</a>.</p> </div> <div class="abstract" title="abstract"> <div class="title" tagx="title" title="title">
Graphical abstract</div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/" /></div>  </div> </div> <div class="abstract" title="abstract"> <div class="title" tagx="title" title="title">
Highlights</div> <p> </p><ul> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0010">Detailed instructions are given for ligand modification by fragment growing</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0015">Conformational sampling is performed by molecular dynamics simulation</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0020">Binding free energy of a protein-ligand complex is computationally evaluated</p> </li> </ul> <p /> </div> <div class="abstract" title="abstract"> <p>Hit-to-lead (H2L) optimization is crucial for drug design, which has become an increasing concern in medicinal chemistry. A virtual screening strategy of auto <i>in silico</i> ligand directing evolution (AILDE) has been developed to yield promising lead compounds rapidly and efficiently. The protocol includes instructions for fragment compound library construction, conformational sampling by molecular dynamics simulation, ligand modification by fragment growing, as well as the binding free energy prediction.</p> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Subject areas</div> <div class="kwd" title="kwd">
Bioinformatics</div> <div class="kwd" title="kwd">
Protein biochemistry</div> <div class="kwd" title="kwd">
Structural biology</div> </div> </div> </div> <div class="body" title="body"> <div class="beforeyoubegin" title="sec"> <div class="title" tagx="title" title="title">
Before you begin</div> <p id="p0025">Auto <i>in silico</i> ligand directing evolution (AILDE) is an effective approach to rapidly explore the structure-activity relationship for H2L optimization (<a href="#bib11">Wu etÂ al., 2020</a>). AILDE is utilized to optimize a hit compound by minor chemical modifications on its scaffold. Minimal increases or losses for the binding efficiency of ligand could be obtained by these modifications. Hence, this method can help us for the exploration of the chemical space around a hit compound and promote the optimization of the hit compound into more drug-like lead compounds. <a href="#fig1">FigureÂ 1</a> shows the workflow of AILDE. AILDE is based on molecular dynamics (MD) simulation complemented with one-step free energy perturbation (FEP) (<a href="#bib2">Hao etÂ al., 2015</a>; <a href="#bib10">Wu etÂ al., 2018</a>). MD simulation is firstly performed on the protein-hit complex. The equilibrated conformational ensemble is then collected. The hit ligand in each conformation is modified to new ligand with substitution using the fragment library. The binding free energy changes between protein-hit and hit analogs are calculated. New leads are finally determined based on the rank of the binding affinity changes. </p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">FigureÂ 1</span></a></div>   <p>Workflow of the AILDE method</p> <p>Once an initial protein-hit complex structure is provided, AILDE will conduct the hit-to-lead optimization according to the following steps: (1) molecular dynamics simulation: this allow to simulate the structural flexibility of the protein-hit complex; (2) collecting the conformational ensemble: adequately collect the representative conformations of a protein-hit complex; (3) generating the hit analogues: a fragment growing based method is utilized to convert a hit to analogue compounds. The conformations of protein-analogues complex are obtained from the representative conformations of the protein-hit complex; (4) binding free energy change: comparing the binding free energy of protein-hit and protein-analogues complexes. Identifying the potential lead compounds according to the rank of the binding free energy changes.</p>   </div> <p /> <p id="p0030">We should provide a productive computational environment for the usage of AILDE. We need a high performance computer with a Unix-based operating system to perform this protocol. A graphics processing unit (GPU) equipment is advised to be used to accelerate the process of molecular dynamics simulation. The prerequisite software (in the <a href="#sec2">materials and equipment</a> section) is freely available on the corresponding websites. The detail introduction about the installation is provided in their user manuals. These software are utilized in different procedures. We download the source code of AILDE at <a href="https://github.com/fwangccnu/AILDE">https://github.com/fwangccnu/AILDE</a>. After configuration of the computational environment, we prepare the input data according to the following steps.</p> <div class="preparingtheinputstructurefileoftheproteincomplexwithahitligand" title="sec"> <div class="title" tagx="title" title="title">
Preparing the input structure file of the protein complex with a hit ligand</div> <p id="p0035"> </p><div class="disp-quote" title="disp-quote"> <p><span class="inline-graphic" title="inline-graphic" /><b>Timing: âˆ¼15Â min</b></p> </div> <ul> <li><span class="label" tagx="label" title="label">1.</span><p id="p0040">Download the structure file of our interest protein complex with a hit ligand from RCSB Protein Data Bank (PDB) (<a href="https://www.rcsb.org/">https://www.rcsb.org/</a>). For example, search the PDB ID of <a href="pdb:2P3B">2P3B</a> in PDB database, and obtain the result of the crystal structure of the subtype B wild type HIV protease complexes with TL-3 inhibitor. And save the PDB format structure file.</p> </li> <li><span class="label" tagx="label" title="label">2.</span><p id="p0045">Open the structure file by Chimera software, keep the hit ligand and its direct interacting protein chain and delete all the irrelative molecules, and save as a processed PDB format structure file. <a href="#fig2">FigureÂ 2</a>A shows the example of deleting the irrelative atoms by Chimera software. A detail document about the usage of Chimera is available on the website (<a href="https://www.cgl.ucsf.edu/chimera/docindex.html">https://www.cgl.ucsf.edu/chimera/docindex.html</a>). </p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">FigureÂ 2</span></a></div>   <p>The complex structure file preparation</p> <p>(A) Illustration of selecting and deleting the irrelative atoms from the complex by Chimera software.</p> <p>(B) Example of renaming amino acids according to their protonated states and adding a â€œTERâ€� record. The positions of proton in different protonated states are highlighted in red: HID represents histidine with hydrogen on the delta nitrogen, HIE on the epsilon nitrogen, and HIP on both nitrogens.</p> <p>(C) Illustration of the structure preparation by the Dock Prep module in Chimera. This module can perform some complex operations, such as deleting solvent and isolated ions, keeping only the conformation with highest occupancy, repairing missing atoms, and adding hydrogen atoms.</p>   </div> <p /> </li> <li><span class="label" tagx="label" title="label">3.</span><p id="p0050">Text edit the processed structure file. Rename MSE residues as MET, and rename HIS as HID, HIE, or HIP based on the protonated states (<a href="#fig2">FigureÂ 2</a>B). And add a â€œTERâ€� record to indicate that the chains are not physically connected to each other. If there are alternative conformations of the residues, keep only the highest occupancy. These operations can be conducted by Chimera software (<a href="#fig2">FigureÂ 2</a>C).</p> </li> </ul> <div class="disp-quote" title="disp-quote"> <p><b><i>Note:</i></b> Alternatively, we can obtain the complex structure of a protein with a hit ligand by molecular docking method (<a href="#bib6">Meng etÂ al., 2011</a>).</p> </div> <div class="disp-quote" title="disp-quote"> <p><span class="inline-graphic" title="inline-graphic" /><b>CRITICAL:</b> It requires the complex structure file to strictly abide by a standard PDB format, and a description about PDB format file is accessed at <a href="http://www.wwpdb.org/documentation/file-format-content/format33/v3.3.html">http://www.wwpdb.org/documentation/file-format-content/format33/v3.3.html</a>.</p> </div> <p /> </div> </div> <div class="keyresourcestable" title="sec"> <div class="title" tagx="title" title="title">
Key resources table</div> <p id="p0455"> <div class="table-wrap_UNKNOWN" position="float" id="undtbl1"> </div></p><table frame="hsides" rules="groups"> <thead> <tr> <th>REAGENT or RESOURCE</th> <th>SOURCE</th> <th>IDENTIFIER</th> </tr> </thead> <tbody> <tr> <td colspan="3"><b>Deposited data</b></td> </tr> <tr> <td colspan="3"> <hr /> </td> </tr> <tr> <td>Three-dimensional structure</td> <td>RCSB Protein Data Bank (PDB)</td> <td>PDB: <a href="pdb:2P3B">2P3B</a></td> </tr> <tr> <td>ZINC</td> <td>(<a href="#bib4">Irwin and Shoichet, 2005</a>)</td> <td><a href="http://zinc12.docking.org/browse/subsets/">http://zinc12.docking.org/browse/subsets/</a></td> </tr> <tr> <td>FDB-17</td> <td>(<a href="#bib9">Visini etÂ al., 2017</a>)</td> <td><a href="https://gdb.unibe.ch/tools/">https://gdb.unibe.ch/tools/</a></td> </tr> <tr> <td>PADFrag</td> <td>(<a href="#bib12">Yang etÂ al., 2018</a>)</td> <td><a href="http://chemyang.ccnu.edu.cn/ccb/database/PADFrag/index.php/help/download">http://chemyang.ccnu.edu.cn/ccb/database/PADFrag/index.php/help/download</a></td> </tr> <tr> <td colspan="3"> <hr /> </td> </tr> <tr> <td colspan="3"><b>Software and algorithms</b></td> </tr> <tr> <td colspan="3"> <hr /> </td> </tr> <tr> <td>AILDE source code</td> <td>This study</td> <td><a href="https://github.com/fwangccnu/AILDE">https://github.com/fwangccnu/AILDE</a></td> </tr> </tbody> </table>  <p /> </div> <div class="materialsandequipment" title="sec"> <div class="title" tagx="title" title="title">
Materials and equipment</div> <div class="equipment" title="sec"> <div class="title" tagx="title" title="title">
Equipment</div> <p id="p0055"> </p><ul> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0060">Computer: a computational workstation installed with proper software listed below is required.</p> </li> <li> <p id="p0065">List of hardware of the computational workstation:</p> </li> <li> <p id="p0070">CPU: Intel Core i5-6400 3.3GHz 4-core processor</p> </li> <li> <p id="p0075">Memory: Kingston KVR16N11/8 8GB DDR3-1600</p> </li> <li> <p id="p0080">GPU: GeForce GTX 1060 3GB</p> </li> <li> <p id="p0085">Storage: Western Digital WD10EZEX 1TB</p> </li> </ul> <p /> </div> <div class="software" title="sec"> <div class="title" tagx="title" title="title">
Software</div> <p id="p0090"> </p><ul> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0095">Chimera (version 1.13 or later, <a href="https://www.cgl.ucsf.edu/chimera/">https://www.cgl.ucsf.edu/chimera/</a>)</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0100">OpenBabel (version 2.3.2 or later, <a href="http://openbabel.org/wiki/Main_Page">http://openbabel.org/wiki/Main_Page</a>)</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0105">Python (version 2.7, <a href="https://www.python.org/">https://www.python.org/</a>)</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0110">Amber and AmberTools (version 16, <a href="https://ambermd.org/">https://ambermd.org/</a>)</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0115">Autogrow (<a href="http://autogrow.ucsd.edu/">http://autogrow.ucsd.edu/</a>)</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0120">R package (version 3.0.0 or later, <a href="https://www.r-project.org/">https://www.r-project.org/</a>)</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0125">A molecular visualizing software for viewing the complex structures, such as VMD (<a href="https://www.ks.uiuc.edu/Research/vmd/">https://www.ks.uiuc.edu/Research/vmd/</a>) or PyMOL (<a href="https://pymol.org/2/">https://pymol.org/2/</a>).</p> </li> </ul> <p /> </div> </div> <div class="step-by-stepmethoddetails" title="sec"> <div class="title" tagx="title" title="title">
Step-by-step method details</div> <div class="afragmentlibraryconstruction" title="sec"> <div class="title" tagx="title" title="title">
A fragment library construction</div> <p id="p0130"> </p><div class="disp-quote" title="disp-quote"> <p><span class="inline-graphic" title="inline-graphic" /><b>Timing: âˆ¼3 h</b></p> </div> <ul> <li><span class="label" tagx="label" title="label">1.</span><p id="p0135">Create the three-dimensional structures of all fragments by Chimera software (<a href="#fig3">FigureÂ 3</a>). The fragments are used to link with the hit compound to generate the hit analogs (<a href="#bib3">Hoffer etÂ al., 2018</a>). All the hydrogen atoms should be deleted in the fragment molecules, except the hydrogen atoms located at the linking point. </p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">FigureÂ 3</span></a></div>   <p>Construction of stereoscopic conformation of a fragment molecule</p> <p>The Build Structure module in Chimera provides several ways to manipulate a molecular structure. This snapshot shows the procedure for building a benzene molecule.</p>   </div> <p /> </li> </ul> <p /> <p id="p0140">Due to the fixed format of a PDB file, it is easy to do these by the scripts in batch mode. We can delete all the hydrogen atoms in a PDB file except the linking point of a hydrogen atom (serial number: <i>id</i>) by a line of bash command: </p><ul> <li> <p id="p0145">awk '{if ($NFÂ == "H" &amp;amp;&amp;amp; $2 != id) {} else {print}}' fragment_H.pdb &amp;gt; fragment_noH.pdb</p> </li> </ul> <p /> <p id="p0150">where <i>id</i> is the serial number of a hydrogen atom as the linking point, <i>fragment_H.pdb</i> is the pdb file of a fragment molecule with all hydrogen atoms, <i>fragment_noH.pdb</i> is the fragment molecule with only a hydrogen atom.</p> <p id="p0155">For a large number of fragments, we just need to use the loop function to deal with each individual repeatedly: </p><ul> <li> <p id="p0160">for i in $(ls âˆ—.pdb)</p> </li> <li> <p id="p0165">do </p><ul> <li> <p id="p0170">fragname=$(basename ${i} .pdb)</p> </li> <li> <p id="p0175">for j in $( awk '{if ($NFÂ == "H") {print $2}}' ${i})</p> </li> <li> <p id="p0180">do </p><ul> <li> <p id="p0185">awk '{if ($NFÂ == "H" &amp;amp;&amp;amp; $2 != â€œâ€˜${j}â€™â€�) {} else {print}}' ${i} &amp;gt; ${fragname}_${j}.pdb</p> </li> </ul> <p /> </li> <li> <p id="p0190">done</p> </li> </ul> <p /> </li> <li> <p id="p0195">done</p> </li> </ul> <p /> <p id="p0200">We can save the above bash codes in a text file (for example: a file named <i>del_H.sh</i>) in the same directory as the fragment PDB files. And run the scripts by type the following in the command line: </p><ul> <li> <p id="p0205">bash del_H.sh</p> </li> </ul> <p /> <p id="p0210">The processed PDB files of fragments are generated in the directory. </p><ul> <li><span class="label" tagx="label" title="label">2.</span><p id="p0215">Perform the conformational optimization on the fragment molecules by Chimera software.</p> </li> <li><span class="label" tagx="label" title="label">3.</span><p id="p0220">Save the structure files of those processed fragment molecules in PDB format.</p> </li> </ul> <div class="disp-quote" title="disp-quote"> <p><b><i>Note:</i></b> The fragment molecules can be download from public fragment databases (<a href="#bib4">Irwin and Shoichet, 2005</a>; <a href="#bib9">Visini etÂ al., 2017</a>; <a href="#bib12">Yang etÂ al., 2018</a>). The related website links are available in the <a href="#sec8">key resources table</a>.</p> </div> <p /> </div> <div class="preparinginputparameterdata" title="sec"> <div class="title" tagx="title" title="title">
Preparing input parameter data</div> <p id="p0225"> </p><div class="disp-quote" title="disp-quote"> <p><span class="inline-graphic" title="inline-graphic" /><b>Timing: âˆ¼5Â min</b></p> </div> <p /> <p id="p0230">Prepare an input parameter file, in which all the parameters for AILDE calculation are contained. </p><ul> <li><span class="label" tagx="label" title="label">4.</span><p id="p0235">Create a parameter file which contains all the necessary parameters for AILDE protocol (<a href="#fig4">FigureÂ 4</a>). Mandatory parameters are â€œstep,â€� â€œcomplex,â€� â€œligand_name,â€� â€œligand_charge,â€� â€œparallel,â€� â€œMDstart,â€� â€œMDend,â€� â€œmm_pbsa,â€� â€œmd_request,â€� and â€œentropy.â€� Each parameter has a default value. </p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">FigureÂ 4</span></a></div>   <p>Preparing the input parameter file</p> <p>(A) The snapshot of webpage for downloading the example parameter file at <a href="https://github.com/fwangccnu/AILDE">https://github.com/fwangccnu/AILDE</a>.</p> <p>(B) The content in the example parameter file.</p>   </div> <p /> </li> <li><span class="label" tagx="label" title="label">5.</span><p id="p0240">An example parameter file is provided in the AILDE source code (<a href="#fig4">FigureÂ 4</a>). A standard format must be followed to define the parameters. Among those parameters, the following three parameters should be adjusted according to actual situation: </p><ul> <li><span class="label" tagx="label" title="label">a.</span><p id="p0245">complex: define the structure file name of the protein complex with hit ligand.</p> </li> <li><span class="label" tagx="label" title="label">b.</span><p id="p0250">ligand_name: define the name of the hit ligand in the complex structure file.</p> </li> <li><span class="label" tagx="label" title="label">c.</span><p id="p0255">md_request: define whether structural relaxation is performed on the newly obtained hit analogs-protein complex by molecular dynamics (MD) simulation.</p> </li> </ul> <p /> </li> <li><span class="label" tagx="label" title="label">6.</span><p id="p0260">Other parameters can be maintained as default value and the detail descriptions about these parameters are recorded in the template parameter file (<a href="#sec6.1">Troubleshooting 1</a>).</p> </li> </ul> <div class="disp-quote" title="disp-quote"> <p><span class="inline-graphic" title="inline-graphic" /><b>CRITICAL:</b> The parameters should be accordant with the actual situations and abide by the format in the example parameter file.</p> </div> <p /> </div> <div class="moleculardynamicssimulationoftheprotein-hitcomplex" title="sec"> <div class="title" tagx="title" title="title">
Molecular dynamics simulation of the protein-hit complex</div> <p id="p0265"> </p><div class="disp-quote" title="disp-quote"> <p><span class="inline-graphic" title="inline-graphic" /><b>Timing: âˆ¼3 h</b></p> </div> <p /> <p id="p0270">In this stage, conformational sampling on the protein complex with hit ligand is conducted by molecular dynamics simulation (<a href="#bib5">Maximova etÂ al., 2016</a>). </p><ul> <li><span class="label" tagx="label" title="label">7.</span><p id="p0275">The topology and coordinate file for the solvated protein-hit complex is generated by <i>tleap</i> module in Amber program. Protein was parameterized by Amber ff14SB force filed and the hit compound molecule by the general Amber force field (GAFF). AM1-BCC charge was assigned for the hit compound by <i>antechamber</i> module in Amber. The complex system was then solvated in the cube box of the TIP3P water model with a distance of 10Â Ã… between the solute and box. The counter-ions (Cl<sup>âˆ’</sup> or Na<sup>+</sup>) were then added to neutralize the solvated protein-hit system.</p> </li> <li><span class="label" tagx="label" title="label">8.</span><p id="p0280">Three cycles of energy minimization are performed on the system by <i>sander</i> module in Amber program. Each cycle includes 5,000 steps of steepest descent, followed by 5,000 steps of conjugated gradient minimization with a final convergence criterion of 0.2Â kcalâˆ™mol<sup>âˆ’1</sup>. The following shows a brief description about three cycles of energy minimization: </p><ul> <li><span class="label" tagx="label" title="label">a.</span><p id="p0285">Cycle 1: the heavy atoms in protein and hit compound are restrained with an elastic constant of 50Â kcalâˆ™mol<sup>âˆ’1</sup>âˆ™Ã…<sup>âˆ’2</sup>. The water molecules, ions, and hydrogen atoms are allowed to move for relaxation.</p> </li> <li><span class="label" tagx="label" title="label">b.</span><p id="p0290">Cycle 2: protein side-chains are also allowed to relax in this step. Only the heavy atoms in the backbone of the protein are restrained with an elastic constant of 50Â kcalâˆ™mol<sup>âˆ’1</sup>âˆ™Ã…<sup>âˆ’2</sup>.</p> </li> <li><span class="label" tagx="label" title="label">c.</span><p id="p0295">Cycle 3: the whole system is minimized.</p> </li> </ul> <p /> </li> <li><span class="label" tagx="label" title="label">9.</span><p id="p0300">Molecular dynamics simulation is then performed on the protein-hit complex with the periodic boundary condition in the NPT ensemble. The detail steps are described as the following: </p><ul> <li><span class="label" tagx="label" title="label">a.</span><p id="p0305">The solvated system is heated gradually from 0 to 298 K in the NVT ensemble during a period of 500 ps.</p> </li> <li><span class="label" tagx="label" title="label">b.</span><p id="p0310">The heated system is equilibrated in the NPT ensemble during a period of 1Â ns.</p> </li> <li><span class="label" tagx="label" title="label">c.</span><p id="p0315">Production simulation at the temperature of 298 K and the pressure of 1 atm. The SHAKE algorithm is used to constrain all covalent bonds involving hydrogens. The particle mesh Ewald (PME) algorithm is used to calculate long-range electrostatic interactions and the short-range van der Waals (vdW) interactions is handled with a cutoff distance of 10Â Ã…. The integration of the equations of motion is conducted at a time step of 2 fs. Finally, 1Â ns production simulation is performed and the structure snapshots are collected every 1Â ps (<a href="#sec6.3">Troubleshooting 2</a>).</p> </li> </ul> <p /> </li> <li><span class="label" tagx="label" title="label">10.</span><p id="p0320">The fluctuations of the protein and hit compound are measured by root-mean-square deviations (RMSD) against their initial structures. The stability of the MD simulation is reflected by their RMSD values, which reveal the conformational changes during the time period of MD simulation. A plateau RMSD value means that the protein-hit complex is in the equilibration state, and that the simulation moves toward the stability status.</p> </li> </ul> <p /> </div> <div class="collectingtheconformationalensembleofprotein-hitcomplex" title="sec"> <div class="title" tagx="title" title="title">
Collecting the conformational ensemble of protein-hit complex</div> <p id="p0325"> </p><div class="disp-quote" title="disp-quote"> <p><span class="inline-graphic" title="inline-graphic" /><b>Timing: âˆ¼10Â min</b></p> </div> <p /> <p id="p0330">After the molecular dynamics simulation, we collected the representative conformations from the equilibrated simulation trajectories. Consideration of structural flexibility has an effect on the accuracy of binding free energy calculation. Predicting free energy changes using structural ensembles has better performance than that using static structures (<a href="#bib1">Benedix etÂ al., 2009</a>). </p><ul> <li><span class="label" tagx="label" title="label">11.</span><p id="p0335">50 snapshots are extracted from the last 1Â ns simulation trajectory by the cpptraj module in Amber program.</p> </li> </ul> <p /> </div> <div class="fragmentgrowingtogeneratethehitanalogs" title="sec"> <div class="title" tagx="title" title="title">
Fragment growing to generate the hit analogs</div> <p id="p0340"> </p><div class="disp-quote" title="disp-quote"> <p><span class="inline-graphic" title="inline-graphic" /><b>Timing: âˆ¼1 h</b></p> </div> <p /> <p id="p0345">In this stage, AILDE generates hit analogs by linking the fragment molecules with the hit ligand in the initial protein complex (<a href="#fig5">FigureÂ 5</a>). </p><ul> <li><span class="label" tagx="label" title="label">12.</span><p id="p0350">All fragment molecules in our fragment library are linked with the hit ligand by AutoGrow software.</p> </li> <li><span class="label" tagx="label" title="label">13.</span><p id="p0355">The generated compounds with the protein are saved as protein-analogs complexes. The complex structures are relaxed by energy minimization via one of the following two strategies: </p><ul> <li><span class="label" tagx="label" title="label">a.</span><p id="p0360">When the parameter â€œmd_requestâ€� is set to â€œNO,â€� structural relaxation without molecular dynamics simulation will be performed. First, all the backbone atoms of protein and the ligand are restrained with an elastic constant of 50Â kcalâˆ™mol<sup>âˆ’1</sup>âˆ™Ã…<sup>âˆ’2</sup>. Then the whole system is minimized. Each of the two minimization steps includes 5,000 cycles of steepest descent and 5,000 cycles of conjugated gradient optimization with a convergence criterion of 0.2Â kcalâˆ™mol<sup>âˆ’1</sup>.</p> </li> <li><span class="label" tagx="label" title="label">b.</span><p id="p0365">When the parameter â€œmd_requestâ€� is set to â€œYES,â€� structural relaxation with molecular dynamics simulation will be performed. The above two cycles of energy minimizations is performed. Then a short period of MD simulation is performed to relax the side-chain atoms.</p> </li> </ul> <p /> </li> <li><span class="label" tagx="label" title="label">14.</span><p id="p0370">All the structure snapshots of protein-hit complex are relaxed by the same strategy as mentioned above (<a href="#sec6.5">Troubleshooting 3</a>).</p> </li> </ul> <div class="disp-quote" title="disp-quote"> <p><b><i>Note:</i></b> In our previous study (<a href="#bib11">Wu etÂ al., 2020</a>), structural relaxation with molecular dynamics simulation may provide more accurate binding free energy results, but at the cost of more computing resources.</p> </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">FigureÂ 5</span></a></div>   <p>Lead compounds generation by fragment growing strategy</p> <p>This illustrates the process of converting a hit compound to a lead compound by fragment linking with the former.</p>   </div> <p /> </div> <div class="predictingfreeenergychangesforbindingaffinities" title="sec"> <div class="title" tagx="title" title="title">
Predicting free energy changes for binding affinities</div> <p id="p0375"> </p><div class="disp-quote" title="disp-quote"> <p><span class="inline-graphic" title="inline-graphic" /><b>Timing: âˆ¼2 h</b></p> </div> <p /> <p id="p0380">In this stage, we calculate the binding affinity (Î"G<sub>bind</sub>) of protein-hit and protein-analogs complexes, then compare the differences of binding free energy change (Î"Î"G) between protein-hit and protein-analogs complexes. </p><ul> <li><span class="label" tagx="label" title="label">15.</span><p id="p0385">The binding affinity Î"G<sub>bind</sub> can be decomposed into three main energy terms, including the molecular mechanical gas-phase interaction energy (Î"E<sub>MM</sub>), desolvation energy (Î"G<sub>sol</sub>) and the change of conformational entropy (â€"TÎ"S). Î"E<sub>MM</sub> and Î"G<sub>sol</sub> are calculated by the MMPBSA module in Amber program. â€"TÎ"S is calculated using our in-house scripts. The entropy contribution is temperature-dependent and can be divided to two contributions: solvation entropy (<i>Î"S</i><sub><i>solv</i></sub>) and conformational entropy (<i>Î"S</i><sub><i>conf</i></sub>). The solvation entropy consists of the apolar and polar solvation entropy, which is typically given by an empirical formula that is proportional to the apolar and polar solvent accessible surface area differences. We use the <i>molsurf</i> and <i>surf</i> modules in Amber program to calculate the solvent accessible surface area. The conformational entropy is related to the change of the number of rotatable bonds during the binding process. The change of the conformational entropy is proportional to the number of the lost rotatable bonds during the binding process. The <i>conf</i> module in Amber is used to calculate the number of the rotatable bonds. More details can be found in the previous work (<a href="#bib7">Pan etÂ al., 2008</a>). The binding affinity Î"G<sub>bind</sub> for a complex is the average value of 50 structural snapshots.</p> </li> <li><span class="label" tagx="label" title="label">16.</span><p id="p0390">The binding affinity differences Î"Î"G between the protein-hit and protein-analogs complexes are then obtained as Î"Î"GÂ = Î"G<sub>bind</sub> (Analogs) â€" Î"G<sub>bind</sub> (Hit).</p> </li> </ul> <p /> </div> </div> <div class="expectedoutcomes" title="sec"> <div class="title" tagx="title" title="title">
Expected outcomes</div> <p id="p0395"><a href="#fig6">FigureÂ 6</a> illustrates the examples of the expected outcomes of this protocol. </p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">FigureÂ 6</span></a></div>   <p>Examples of the expected outcomes of AILDE method</p> <p>(A) The calculated binding free energy of the lead compounds with a protein receptor.</p> <p>(B) Heatmap showing the activities of the lead compounds obtained by fragment linking. The horizontal axis represents the fragment molecules, and the vertical axis represents the atomic number of the atoms connecting the fragments. The darker the red, the more active the compound is. The darker the blue, the less active the compound is.</p> <p>(C) The interaction modes of the lead compounds with protein receptor.</p>   </div> <p /> <p id="p0400">We obtain a series of hit analogs from the initial hit molecule. The binding affinity of each analog compound interacting with the protein has been evaluated. Then the binding affinity changes between the protein-analogs and protein-hit complexes are calculated. A negative change of binding free energy indicates an increase in the binding affinity, while a positive change of binding free energy indicates a decrease in the binding affinity. Potential lead compounds are identified based on the rank of the changes of binding free energy. <a href="#fig6">FigureÂ 6</a>A shows the results of the binding affinity changes, which contain the information about the analog compound structures, fragment molecules, substituent positions, and binding affinity changes. In addition, a heatmap is plotted to graphically display the relationship between the generated analog compounds and their binding affinity changes (<a href="#fig6">FigureÂ 6</a>B). The horizontal axis represents fragment molecules, and the vertical axis represents hydrogen atoms where the fragment molecules are linked. The darker the red, the more active the compound is. The darker the blue, the less active the compound is. AILDE not only generates the analog compounds, also predict their binding poses in the protein. The binding modes of the compounds interacting with the protein are explored by analyze the complex structures (<a href="#fig6">FigureÂ 6</a>C).</p> </div> <div class="limitations" title="sec"> <div class="title" tagx="title" title="title">
Limitations</div> <p id="p0405">AILDE is based on an assumption that there are no substantial changes in the binding modes between protein-hit and protein-analogs complexes. AILDE could not achieve a good performance in a complicated situation of activity cliffs. This is caused by the compounds with similar structures, but have large differences in binding affinity (<a href="#bib8">Stumpfe and Bajorath, 2012</a>). In this protocol, a small fragment library is applied to generate the potential lead compounds. It is suggested to utilize larger chemical space to search and predict more possible lead compounds. The molecular weight of a fragment molecule is recommend to be less than 90 g/mol for a good performance.</p> </div> <div class="troubleshooting" title="sec"> <div class="title" tagx="title" title="title">
Troubleshooting</div> <div class="problem1" title="sec"> <div class="title" tagx="title" title="title">
Problem 1</div> <p id="p0410">AILDE reminders that there are any files not found.</p> </div> <div class="potentialsolution" title="sec"> <div class="title" tagx="title" title="title">
Potential solution</div> <p id="p0415">All the input files for AILDE are identified in the parameter file. We should prepare a suitable parameter file according to the example file provided in AILDE source code. We recommend changing the paths of the necessary data file in the example file.</p> </div> <div class="problem2" title="sec"> <div class="title" tagx="title" title="title">
Problem 2</div> <p id="p0420">The molecular dynamics simulation terminates abnormally.</p> </div> <div class="potentialsolution" title="sec"> <div class="title" tagx="title" title="title">
Potential solution</div> <p id="p0425">We recommend using the protein complex with only one ligand compound as the initial structure to perform the molecular dynamics simulation. In preparing the input structure file of the protein complex with a hit ligand, we could remove the unconcerned chemical compounds in the complex structure.</p> </div> <div class="problem3" title="sec"> <div class="title" tagx="title" title="title">
Problem 3</div> <p id="p0430">The structures of the hit analogs generated by fragment growing are weird.</p> </div> <div class="potentialsolution" title="sec"> <div class="title" tagx="title" title="title">
Potential solution</div> <p id="p0435">We recommend that the conformational optimization should be performed for the fragment molecules in the step of a fragment library construction. Chimera software could be used to conduct the optimization.</p> </div> </div> <div class="resourceavailability" title="sec"> <div class="title" tagx="title" title="title">
Resource availability</div> <div class="leadcontact" title="sec"> <div class="title" tagx="title" title="title">
Lead contact</div> <p id="p0440">Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Gefei Hao (<a href="mailto:gefei_hao@foxmail.com">gefei_hao@foxmail.com</a>).</p> </div> <div class="materialsavailability" title="sec"> <div class="title" tagx="title" title="title">
Materials availability</div> <p id="p0445">This study did not generate new unique reagents.</p> </div> <div class="data-availability" title="data-availability"> <div class="title" tagx="title" title="title">
Data and code availability</div> <p id="p0450">The online web service of AILDE can be accessed at <a href="http://chemyang.ccnu.edu.cn/ccb/server/AILDE">http://chemyang.ccnu.edu.cn/ccb/server/AILDE</a>. The code of AILDE can be downloaded at <a href="https://github.com/fwangccnu/AILDE">https://github.com/fwangccnu/AILDE</a>.</p> </div> </div> </div> <div class="back" title="back"> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="bib1" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Benedix</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Becker</span><span class="given-names" tagx="given-names" title="given-names">C.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">de Groot</span><span class="given-names" tagx="given-names" title="given-names">B.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Caflisch</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bockmann</span><span class="given-names" tagx="given-names" title="given-names">R.A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Predicting free energy changes using structural ensembles</span><span class="source" tagx="source" title="source">Nat. Methods</span><span class="volume" tagx="volume" title="volume">6</span><span class="year" tagx="year" title="year">2009</span><span class="fpage" tagx="fpage" title="fpage">3</span><span class="lpage" tagx="lpage" title="lpage">4</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19116609">19116609</a></span></span></li> <li tag="ref"><a name="bib2" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hao</span><span class="given-names" tagx="given-names" title="given-names">G.-F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">S.-G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shen</span><span class="given-names" tagx="given-names" title="given-names">Y.-Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tu</span><span class="given-names" tagx="given-names" title="given-names">W.-L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">L.-S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">J.-W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Berry</span><span class="given-names" tagx="given-names" title="given-names">E.A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Rational design of highly potent and slow-binding cytochrome bc1 inhibitor as fungicide by computational substitution optimization</span><span class="source" tagx="source" title="source">Sci. Rep.</span><span class="volume" tagx="volume" title="volume">5</span><span class="year" tagx="year" title="year">2015</span><span class="fpage" tagx="fpage" title="fpage">13471</span></span></li> <li tag="ref"><a name="bib3" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hoffer</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Voitovich</span><span class="given-names" tagx="given-names" title="given-names">Y.V.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Raux</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carrasco</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Muller</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fedorov</span><span class="given-names" tagx="given-names" title="given-names">A.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Derviaux</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Amouric</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Betzi</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Horvath</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Integrated strategy for lead optimization based on fragment growing: the diversity-oriented-target-focused-synthesis approach</span><span class="source" tagx="source" title="source">J.Â Med. Chem.</span><span class="volume" tagx="volume" title="volume">61</span><span class="year" tagx="year" title="year">2018</span><span class="fpage" tagx="fpage" title="fpage">5719</span><span class="lpage" tagx="lpage" title="lpage">5732</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29883107">29883107</a></span></span></li> <li tag="ref"><a name="bib4" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Irwin</span><span class="given-names" tagx="given-names" title="given-names">J.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shoichet</span><span class="given-names" tagx="given-names" title="given-names">B.K.</span></span></span><span class="mixed-article-title" title="mixed-article-title">ZINC--a free database of commercially available compounds for virtual screening</span><span class="source" tagx="source" title="source">J.Â Chem. Inf. Model.</span><span class="volume" tagx="volume" title="volume">45</span><span class="year" tagx="year" title="year">2005</span><span class="fpage" tagx="fpage" title="fpage">177</span><span class="lpage" tagx="lpage" title="lpage">182</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15667143">15667143</a></span></span></li> <li tag="ref"><a name="bib5" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Maximova</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Moffatt</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ma</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nussinov</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shehu</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Principles and overview of sampling methods for modeling macromolecular structure and dynamics</span><span class="source" tagx="source" title="source">PLoS Comput. Biol.</span><span class="volume" tagx="volume" title="volume">12</span><span class="year" tagx="year" title="year">2016</span><span class="fpage" tagx="fpage" title="fpage">e1004619</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27124275">27124275</a></span></span></li> <li tag="ref"><a name="bib6" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meng</span><span class="given-names" tagx="given-names" title="given-names">X.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">H.X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mezei</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cui</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Molecular docking: a powerful approach for structure-based drug discovery</span><span class="source" tagx="source" title="source">Curr. Comput. Aid. Drug Des.</span><span class="volume" tagx="volume" title="volume">7</span><span class="year" tagx="year" title="year">2011</span><span class="fpage" tagx="fpage" title="fpage">146</span><span class="lpage" tagx="lpage" title="lpage">157</span></span></li> <li tag="ref"><a name="bib7" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pan</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gao</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhan</span><span class="given-names" tagx="given-names" title="given-names">C.G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Modeling the catalysis of anti-cocaine catalytic antibody: competing reaction pathways and free energy barriers</span><span class="source" tagx="source" title="source">J.Â Am. Chem. Soc.</span><span class="volume" tagx="volume" title="volume">130</span><span class="year" tagx="year" title="year">2008</span><span class="fpage" tagx="fpage" title="fpage">5140</span><span class="lpage" tagx="lpage" title="lpage">5149</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18341277">18341277</a></span></span></li> <li tag="ref"><a name="bib8" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stumpfe</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bajorath</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Exploring activity cliffs in medicinal chemistry</span><span class="source" tagx="source" title="source">J.Â Med. Chem.</span><span class="volume" tagx="volume" title="volume">55</span><span class="year" tagx="year" title="year">2012</span><span class="fpage" tagx="fpage" title="fpage">2932</span><span class="lpage" tagx="lpage" title="lpage">2942</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22236250">22236250</a></span></span></li> <li tag="ref"><a name="bib9" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Visini</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Awale</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reymond</span><span class="given-names" tagx="given-names" title="given-names">J.L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Fragment database FDB-17</span><span class="source" tagx="source" title="source">J.Â Chem. Inf. Model.</span><span class="volume" tagx="volume" title="volume">57</span><span class="year" tagx="year" title="year">2017</span><span class="fpage" tagx="fpage" title="fpage">700</span><span class="lpage" tagx="lpage" title="lpage">709</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28375006">28375006</a></span></span></li> <li tag="ref"><a name="bib10" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">F.X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">J.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">M.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jia</span><span class="given-names" tagx="given-names" title="given-names">C.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hao</span><span class="given-names" tagx="given-names" title="given-names">G.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">G.F.</span></span></span><span class="mixed-article-title" title="mixed-article-title">AIMMS suite: a web server dedicated for prediction of drug resistance on protein mutation</span><span class="source" tagx="source" title="source">Brief. Bioinform.</span><span class="volume" tagx="volume" title="volume">21</span><span class="year" tagx="year" title="year">2018</span><span class="fpage" tagx="fpage" title="fpage">318</span><span class="lpage" tagx="lpage" title="lpage">328</span></span></li> <li tag="ref"><a name="bib11" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">F.X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhuo</span><span class="given-names" tagx="given-names" title="given-names">L.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hao</span><span class="given-names" tagx="given-names" title="given-names">G.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">G.F.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Auto inÂ silico ligand directing evolution to facilitate the rapid and efficient discovery of drug lead</span><span class="source" tagx="source" title="source">iScience</span><span class="volume" tagx="volume" title="volume">23</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">101179</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32498019">32498019</a></span></span></li> <li tag="ref"><a name="bib12" /><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">J.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">G.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">C.Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">X.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hao</span><span class="given-names" tagx="given-names" title="given-names">G.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">G.F.</span></span></span><span class="mixed-article-title" title="mixed-article-title">PADFrag: a database built for the exploration of bioactive fragment space for drug discovery</span><span class="source" tagx="source" title="source">J.Â Chem. Inf. Model.</span><span class="volume" tagx="volume" title="volume">58</span><span class="year" tagx="year" title="year">2018</span><span class="fpage" tagx="fpage" title="fpage">1725</span><span class="lpage" tagx="lpage" title="lpage">1730</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30134653">30134653</a></span></span></li> </ul> </div> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgments</div> <p id="p0460">This work was supported by the </p><div class="funding-source" title="funding-source"> <div class="institution-wrap" title="institution-wrap"><span class="institution-id" title="institution-id">10.13039/501100001809</span><span class="institution" title="institution">National Natural Science Foundation of China</span></div> </div> (21772059, 91853127, and 31960548), Program of Introducing Talents of Discipline to Universities of China ( <div class="funding-source" title="funding-source">
111 Program</div>, D20023), and Frontiers Science Center for Asymmetric Synthesis and Medicinal Molecules, <div class="funding-source" title="funding-source"> <div class="institution-wrap" title="institution-wrap"><span class="institution-id" title="institution-id">10.13039/501100010828</span><span class="institution" title="institution">Department of Education, Guizhou Province</span></div> </div> (Qianjiaohe KY number (2020)004).<p /> <div class="authorcontributions" title="sec"> <div class="title" tagx="title" title="title">
Author contributions</div> <p id="p0465">Conceptualization, G.H.; programming, F.W.; writing â€" original draft, L.M. and F.W.; writing â€" review &amp;amp; editing, G.H. and G.Y.</p> </div> <div class="COI-statement" title="COI-statement"> <div class="title" tagx="title" title="title">
Declaration of interests</div> <p id="p0470">The authors declare no competing interests.</p> </div> </div> </div>  </body></html>